PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 261 filers reported holding PACIRA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.85 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $208,716 | -95.8% | 6,803 | -94.5% | 0.00% | -95.8% |
| Q2 2023 | $4,983,987 | -38.2% | 124,382 | +8.0% | 0.05% | -11.1% |
| Q1 2021 | $8,071,000 | -14.1% | 115,157 | -26.7% | 0.05% | -30.8% |
| Q4 2020 | $9,400,000 | +1.9% | 157,090 | +2.4% | 0.08% | -22.0% |
| Q3 2020 | $9,225,000 | +6.4% | 153,443 | -7.2% | 0.10% | +4.2% |
| Q2 2020 | $8,673,000 | +29806.9% | 165,300 | +18813.0% | 0.10% | – |
| Q1 2020 | $29,000 | -21.6% | 874 | +7.1% | 0.00% | – |
| Q4 2019 | $37,000 | -7.5% | 816 | -23.0% | 0.00% | – |
| Q3 2019 | $40,000 | – | 1,060 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GAGNON SECURITIES LLC | 563,415 | $21,753,453 | 4.80% |
| Gagnon Advisors, LLC | 180,331 | $6,962,579 | 4.70% |
| Spyglass Capital Management LLC | 868,686 | $33,539,966 | 2.69% |
| Tamarack Advisers, LP | 100,000 | $3,861,000 | 1.99% |
| ARMISTICE CAPITAL, LLC | 1,892,000 | $73,050,120 | 1.27% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 276,590 | $10,679,140 | 0.99% |
| RICE HALL JAMES & ASSOCIATES, LLC | 437,285 | $16,883,574 | 0.97% |
| Rock Springs Capital Management LP | 1,032,600 | $39,868,686 | 0.96% |
| OUTFITTER FINANCIAL LLC | 25,860 | $998,455 | 0.91% |
| Stephens Investment Management Group LLC | 1,168,469 | $45,535,237 | 0.82% |